Gilead Sciences
Venture capital · Foster City, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
2Deep-tech portfolio0 active
2Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Grail
5Co-investorsShare a portfolio company
Portfolio · 2 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Grail | Medtech | Public | Nov 7, 2025 | $1.7B |
| Immunomedics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#189
Portfolio exits#103
Raises, 12 months#22
Co-investors#198
Co-investors
- Breakthrough Energy VenturesVenture capital1 shared
- Bristol-Myers SquibbVenture capital1 shared
- IlluminaVenture capital1 shared
- Johnson & Johnson Development CorporationVenture capital1 shared
- SeagenVenture capital1 shared
Sectors
- Medtech1
- Biotech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.